Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA.

Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584. Review.

2.

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.

Greenhalgh J, Dwan K, Boland A, Bates V, Vecchio F, Dundar Y, Jain P, Green JA.

Cochrane Database Syst Rev. 2016 May 25;(5):CD010383. doi: 10.1002/14651858.CD010383.pub2. Review.

PMID:
27223332
3.

Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.

Yano T, Haro A, Shikada Y, Maruyama R, Maehara Y.

Int J Clin Oncol. 2011 Aug;16(4):287-93. doi: 10.1007/s10147-010-0160-8. Epub 2011 May 13. Review.

PMID:
21562939
4.

[Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer].

André F, Jacot W, Pujol JL, Grunenwald D, Le Chevalier T.

Bull Cancer. 1999 Oct;Suppl 3:17-41. Review. French.

PMID:
10585572
6.

Lung cancer in never smokers: a review.

Subramanian J, Govindan R.

J Clin Oncol. 2007 Feb 10;25(5):561-70. Review.

PMID:
17290066
7.

Lung adenocarcinoma: lessons in translation from bench to bedside.

Sangodkar J, Katz S, Melville H, Narla G.

Mt Sinai J Med. 2010 Nov-Dec;77(6):597-605. doi: 10.1002/msj.20226. Review.

PMID:
21105123
8.

Erlotinib in non-small cell lung cancer treatment: current status and future development.

Gridelli C, Bareschino MA, Schettino C, Rossi A, Maione P, Ciardiello F.

Oncologist. 2007 Jul;12(7):840-9. Review.

9.

Non-small-cell lung cancer.

Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, Shepherd FA.

Lancet. 2011 Nov 12;378(9804):1727-40. doi: 10.1016/S0140-6736(10)62101-0. Epub 2011 May 10. Review.

PMID:
21565398
10.

Treatment of advanced (stages III and IV) non-small-cell lung cancer.

Sweeney CJ, Sandler AB.

Curr Probl Cancer. 1998 Mar-Apr;22(2):85-132. Review.

PMID:
9580849
11.

Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?

Wozniak AJ, Gadgeel SM.

Oncology (Williston Park). 2007 Feb;21(2):163-71; discussion 171, 174, 179-82. Review.

12.

Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.

Bunn PA Jr.

Clin Lung Cancer. 2004 Sep;6(2):85-98. Review.

PMID:
15476594
13.
14.

Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review.

Feld R, Sridhar SS, Shepherd FA, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care..

J Thorac Oncol. 2006 May;1(4):367-76. Review.

15.

First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.

Hirsch FR, Dziadziuszko R, Varella-Garcia M, Franklin WA, Gandara DR, Bunn PA Jr.

J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S138-42. doi: 10.1097/JTO.0b013e318174e922. Review.

16.

Maintenance therapy of gefitinib for non-small-cell lung cancer after first-line chemotherapy regardless of epidermal growth factor receptor mutation: a review in Chinese patients.

Biaoxue R, Shuanying Y, Wei L, Wei Z, Zongjuan M.

Curr Med Res Opin. 2012 Oct;28(10):1699-708. doi: 10.1185/03007995.2012.728525. Epub 2012 Oct 2. Review.

PMID:
22978775
17.

Shifting paradigms in non-small cell lung cancer: an evolving therapeutic landscape.

Riessk J.

Am J Manag Care. 2013 Dec;19(19 Suppl):s390-7. Review.

18.

Evaluation and treatment of patients with non-small cell lung cancer.

Carr LL, Finigan JH, Kern JA.

Med Clin North Am. 2011 Nov;95(6):1041-54. doi: 10.1016/j.mcna.2011.08.001. Review.

PMID:
22032426
19.

[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].

Bergot E, Levallet G, Creveuil C, Lechapt E, Zalcman G.

Presse Med. 2011 Apr;40(4 Pt 1):379-88. doi: 10.1016/j.lpm.2011.01.016. Epub 2011 Mar 3. Review. French.

PMID:
21376511
20.

Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward.

Vijayvergia N, Shah PC, Denlinger CS.

J Natl Compr Canc Netw. 2015 Sep;13(9):1151-61. Review.

PMID:
26358799

Supplemental Content

Support Center